1. Use of PPIs:

3. Prescription and OTC PPIs

4. Evidence-Based Guidance to Understanding PPI Safety

5. PPI Study Trial Design Considerations

6. Confounding Variables, Odds Ratios, and the Matter of Stratification

7. An Evaluation of Concerns Raised Regarding PPI Use

8. PPIs and Risk for MI in the General Population

9. COGENT Trial: PPI + Clopidogrel + ASA vs Placebo + Clopidogrel + ASA

10. Bone Density and PPI Use

11. Bone Integrity and PPI Use

12. PPI Use and Dementia

13. Quantifying the Association Between PPI Use and CKD

14. PPI Use and Risk for CKD

15. PPIs and the Risk for Incident CKD and Progression to ESRD

16. PPI Use and GI Infectious Disease

17. Panel Discussion

18. Abbreviations